p73 is a human p53-related protein that can induce apoptosis

A new technique for the assay of infectivity of human adenovirus 5 DNA

Graham, F. L., & van der Eb, A. J. (1973) · Virology · doi:10.1016/0042-6822(73)90341-3 · Cited by 9,734 · see citing works

Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.

Gavrieli, Y., Sherman, Y., & Ben-Sasson, S. A. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.3.493 · Cited by 9,444 · see citing works

WAF1, a potential mediator of p53 tumor suppression

El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321 · see citing works

p53 Mutations in Human Cancers

Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018 · see citing works

High-Efficiency Transformation of Mammalian Cells by Plasmid DNA

Chen, C., & Okayama, H. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.8.2745 · Cited by 5,374 · see citing works

The p53 tumour suppressor gene

Levine, A. J., Momand, J. A., & Finlay, C. A. (1991) · Nature · doi:10.1038/351453a0 · Cited by 3,785 · see citing works

Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations

Cho, Y., Gorina, S., Jeffrey, P. D., & Pavletich, N. P. (1994) · Science · doi:10.1126/science.8023157 · Cited by 2,559 · cited 1× · see citing works

Suppression of Human Colorectal Carcinoma Cell Growth by Wild-Type p53

Baker, S. J., Markowitz, S. D., Fearon, E. R., Willson, J. K. V., & Vogelstein, B. (1990) · Science · doi:10.1126/science.2144057 · Cited by 1,742 · see citing works

Monoallelically Expressed Gene Related to p53 at 1p36, a Region Frequently Deleted in Neuroblastoma and Other Human Cancers

Kaghad, M., Bonnet, H., Yang, A., Créancier, L., Biscan, J.-C., Valent, A., Minty, A. J., Chalon, P., Lélias, J.-M., Dumont, X., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80540-1 · Cited by 1,630 · see citing works

Oncogenic Forms of p53 Inhibit p53-Regulated Gene Expression

Kern, S. E., Pietenpol, J., Thiagalingam, S., Seymour, A., Kinzler, K. W., & Vogelstein, B. (1992) · Science · doi:10.1126/science.1589764 · Cited by 940 · see citing works

p53 Functions as a Cell Cycle Control Protein in Osteosarcomas

Diller, L., Kassel, J., Nelson, C. E., Gryka, M. A., Litwak, G., Gebhardt, M. C., Bressac, B., Öztürk, M., Baker, S. J., Vogelstein, B., et al. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.11.5772 · Cited by 775 · see citing works

Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues.

El‐Deiry, W. S., Tokino, T., Waldman, T. A., Oliner, J., Velculescu, V. E., Burrell, M., HILL, D. E., Healy, E., Rees, J. L., & Hamilton, S. R. (1995) · PubMed · Cited by 582 · see citing works

Human wee1 maintains mitotic timing by protecting the nucleus from cytoplasmically activated cdc2 kinase

Heald, R., McLoughlin, M., & McKeon, F. (1993) · Cell · doi:10.1016/0092-8674(93)80048-j · Cited by 464 · see citing works

Sequence-specific transcriptional activation is essential for growth suppression by p53.

Pietenpol, J. A., Tokino, T., Thiagalingam, S., El‐Deiry, W. S., Kinzler, K. W., & Vogelstein, B. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.1998 · Cited by 406 · see citing works

Identification of a growth suppression domain within the retinoblastoma gene product.Preprint

Qin, X. Q., Chittenden, T., Livingston, D. M., & Kaelin, W. G. (1992) · Genes & Development · doi:10.1101/gad.6.6.953 · Cited by 404 · see citing works

A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites.

Sellers, W. R., Rodgers, J. W., & Kaelin, W. G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11544 · Cited by 250 · see citing works

Absence of p53 gene mutations in primary neuroblastomas.

Vogan, K. J., Bernstein, M. L., Leclerc, J., Brisson, L., Brossard, J., Brodeur, G. M., Pelletier, J., & Gros, P. (1993) · PubMed · Cited by 196 · see citing works

Biochemical properties and biological effects of p53

Haffner, R., & Oren, M. (1995) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(95)90058-6 · Cited by 177 · see citing works

There may be two tumor suppressor genes on chromosome arm Ip closely associated with biologically distinct subtypes of neuroblastoma

Takeda, O., Homma, C., Maseki, N., Sakurai, M., Kanda, N., Schwab, M., Nakamura, Y., & Kaneko, Y. (1994) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870100106 · Cited by 158 · see citing works

Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N–myc amplification

Caron, H. N., Sluis, P. V., van Hoeve, M., de Kraker, J., Bras, J., Slater, R. M., Mannens, M. M. A. M., Voûte, P. A., Westerveld, A., & Versteeg, R. (1993) · Nature Genetics · doi:10.1038/ng0693-187 · Cited by 134 · see citing works

Cooperative DNA binding of p53 with TFIID (TBP): a possible mechanism for transcriptional activation.Preprint

Chen, X., Farmer, G., Zhu, H., Prywes, R., & Prives, C. L. (1993) · Genes & Development · doi:10.1101/gad.7.10.1837 · Cited by 123 · see citing works

1p36: Every subband a suppressor?

Versteeg, R., Caron, H. N., Cheng, N. C., van der Drift, P., Slater, R. M., Westerveld, A., Voûte, P. A., Delattre, O., Laureys, G., Roy, N. V., et al. (1995) · European Journal of Cancer · doi:10.1016/0959-8049(95)00037-j · Cited by 61 · see citing works

Childhood cancer survivors

Neglia, J. P. (1994) · Cancer · doi:10.1002/1097-0142(19940615)73:12 · Cited by 52 · see citing works

DNA-Binding-Defective Mutants of the Epstein-Barr Virus Lytic Switch Activator Zta Transactivate with Altered Specificities

Flemington, E. K., Lytle, J. P., Cayrol, C., Borras, A. M., & Speck, S. H. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.5.3041 · Cited by 45 · see citing works

p63, a p53 Homolog at 3q27–29, Encodes Multiple Products with Transactivating, Death-Inducing, and Dominant-Negative Activities

Yang, A., Kaghad, M., Wang, Y., Gillett, E. S., Fleming, M. D., Dötsch, V., Andrews, N. C., Caput, D., & McKeon, F. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80275-0 · Cited by 2,086 · see citing works

The p53 pathway: positive and negative feedback loops

Harris, S. L., & Levine, A. J. (2005) · Oncogene · doi:10.1038/sj.onc.1208615 · Cited by 1,967 · see citing works

How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression

Aubrey, B. J., Kelly, G. L., Janic, A., Herold, M. J., & Strasser, A. (2018) · Cell Death & Differentiation · doi:10.1038/cdd.2017.169 · Cited by 1,395 · see citing works

Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome

Olive, K. P., Tuveson, D. A., Ruhe, Z. C., Yin, B., Willis, N. A., Bronson, R. T., Crowley, D., & Jacks, T. (2004) · Cell · doi:10.1016/j.cell.2004.11.004 · Cited by 1,308 · see citing works

p53 and Human Cancer: The First Ten Thousand Mutations

Hainaut, P. L., & Hollstein, M. C. (1999) · Advances in cancer research · doi:10.1016/s0065-230x(08)60785-x · Cited by 980 · see citing works

The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage

Gong, J., Costanzo, A., Yang, H., Melino, G., Kaelin, W. G., Levrero, M., & Wang, J. Y. J. (1999) · Nature · doi:10.1038/21690 · Cited by 923 · see citing works

p53: 800 million years of evolution and 40 years of discovery

Levine, A. J. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-0262-1 · Cited by 850 · see citing works

p63 and p73 are required for p53-dependent apoptosis in response to DNA damage

Flores, E. R., Tsai, K. Y., Crowley, D. G., Sengupta, S., Yang, A., McKeon, F., & Jacks, T. (2002) · Nature · doi:10.1038/416560a · Cited by 801 · see citing works

Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting

Borrero, L. J. H., & El‐Deiry, W. S. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188556 · Cited by 773 · see citing works

Role for the p53 homologue p73 in E2F-1-induced apoptosis

Irwin, M. S., Marín, M. C., Phillips, A. C., Seelan, R. S., Smith, D. I., Liu, W., Flores, E. R., Tsai, K. Y., Jacks, T., Vousden, K. H., et al. (2000) · Nature · doi:10.1038/35036614 · Cited by 710 · see citing works

MDM2 — master regulator of the p53 tumor suppressor protein

Momand, J., Wu, H.-H., & Dasgupta, G. (2000) · Gene · doi:10.1016/s0378-1119(99)00487-4 · Cited by 641 · see citing works

Apaf-1 is a transcriptional target for E2F and p53

Moroni, M. C., Hickman, E. S., Denchi, E. L., Caprara, G., Colli, E., Cecconi, F., Müller, H., & Helin, K. (2001) · Nature Cell Biology · doi:10.1038/35078527 · Cited by 593 · see citing works

p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage

Yuan, Z.-M., Shioya, H., Ishiko, T., Sun, X., Gu, J., Huang, Y., Lu, H., Kharbanda, S. M., Weichselbaum, R. W., & Kufe, D. W. (1999) · Nature · doi:10.1038/21704 · Cited by 574 · see citing works

The p53/p63/p73 family of transcription factors: overlapping and distinct functions

Levrero, M., Laurenzi, V. D., Costanzo, A., Sabatini, S., Gong, J., Wang, J. Y. J., & Melino, G. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.10.1661 · Cited by 563 · see citing works

p73: Friend or foe in tumorigenesis

Melino, G., Laurenzi, V. D., & Vousden, K. H. (2002) · Nature reviews. Cancer · doi:10.1038/nrc861 · Cited by 554 · see citing works

Interaction of c-Abl and p73α and their collaboration to induce apoptosis

Agami, R., Blandino, G., Oren, M., & Shaul, Y. (1999) · Nature · doi:10.1038/21697 · Cited by 544 · see citing works

Cloning and functional analysis of human p51, which structurally and functionally resembles p53

Osada, M., Ohba, M., Kawahara, C., Ishioka, C., Kanamaru, R., Katoh, I., Ikawa, Y., Nimura, Y., Nakagawara, A., Obinata, M., et al. (1998) · Nature Medicine · doi:10.1038/nm0798-839 · Cited by 529 · see citing works

A common polymorphism acts as an intragenic modifier of mutant p53 behaviour

Marín, M. C., Jost, C. A., Brooks, L. A., Irwin, M. S., O’Nions, J., TIDY, J. A., James, N. D., McGregor, J., Harwood, C. A., Yuluğ, I. G., et al. (2000) · Nature Genetics · doi:10.1038/75586 · Cited by 511 · see citing works

The relationship between BcI2, Bax and p53: consequences for cell cycle progression and cell death

Basu, A. (1998) · Molecular Human Reproduction · doi:10.1093/molehr/4.12.1099 · Cited by 491 · see citing works

On the shoulders of giants: p63, p73 and the rise of p53

Yang, A., Kaghad, M., Caput, D., & McKeon, F. (2002) · Trends in Genetics · doi:10.1016/s0168-9525(02)02595-7 · Cited by 486 · see citing works

p63 and p73: Roles in Development and Tumor Formation

Moll, U. M., & Slade, N. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.371.2.7 · Cited by 482 · see citing works

p63 and p73: p53 mimics, menaces and more

Yang, A., & McKeon, F. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35043127 · Cited by 504 · see citing works

A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain

Gaiddon, C., Lokshin, M., Ahn, J., Zhang, T., & Prives, C. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.5.1874-1887.2001 · Cited by 464 · see citing works

An Anti-Apoptotic Role for the p53 Family Member, p73, During Developmental Neuron Death

Pozniak, C. D., Radinovic, S., Yang, A., McKeon, F., Kaplan, D. R., & Miller, F. D. (2000) · Science · doi:10.1126/science.289.5477.304 · Cited by 465 · see citing works

The role of iron in cell cycle progression and the proliferation of neoplastic cells

Le, N. (2002) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(02)00068-9 · Cited by 453 · see citing works

Identification and classification of p53-regulated genes

Yu, J., Zhang, L., Hwang, P. M., Rago, C., Kinzler, K. W., & Vogelstein, B. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14517 · Cited by 452 · see citing works

Physical Interaction with Yes-associated Protein Enhances p73 Transcriptional Activity

Strano, S., Munarriz, E. R., Rossi, M., Castagnoli, L., Shaul, Y., Sacchi, A., Oren, M., Sudol, M., Cesareni, G., & Blandino, G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010484200 · Cited by 418 · see citing works

p73 Function Is Inhibited by Tumor-Derived p53 Mutants in Mammalian Cells

Como, C. J. D., Gaiddon, C., & Prives, C. L. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1438 · Cited by 417 · see citing works

Molecular mechanisms involved in cisplatin cytotoxicity

Jordan, P., & Carmo‐Fonseca, M. (2000) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000762 · Cited by 398 · see citing works

DNA Copy Number Losses in Human Neoplasms

Knuutila, S., Aalto, Y., Autio, K., Björkqvist, A., El-Rifai, W. M., Hemmer, S., Huhta, T., Kettunen, E., Kiuru‐Kuhlefelt, S., Larramendy, M. L., et al. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65166-8 · Cited by 396 · see citing works

p73 Induces apoptosis via PUMA transactivation and Bax mitochondrial translocation

Melino, G., Bernassola, F., Ranalli, M., Yee, K., Zong, W. X., Corazzari, M., Knight, R. A., Green, D. R., Thompson, C., & Vousden, K. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m307469200 · Cited by 368 · see citing works

Two New p73 Splice Variants, γ and δ, with Different Transcriptional Activity

Laurenzi, V. D., Costanzo, A., Barcaroli, D., Terrinoni, A., Falco, M., Annicchiarico‐Petruzzelli, M., Levrero, M., & Melino, G. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.9.1763 · Cited by 366 · see citing works

Role of the p53-homologue p73 in E2F1-induced apoptosis

Stiewe, T., & Pützer, B. M. (2000) · Nature Genetics · doi:10.1038/82617 · Cited by 351 · see citing works

Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members

Moustakas, A., & Kardassis, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6733 · Cited by 354 · see citing works

Yap1 Phosphorylation by c-Abl Is a Critical Step in Selective Activation of Proapoptotic Genes in Response to DNA Damage

Levy, D., Adamovich, Y., Reuven, N. B., & Shaul, Y. (2008) · Molecular Cell · doi:10.1016/j.molcel.2007.12.022 · Cited by 348 · see citing works

Human ΔNp73 regulates a dominant negative feedback loop for TAp73 and p53

Grob, T. J., Novak, U., Maisse, C., Barcaroli, D., Lüthi, A. U., Pirnia, F., Hügli, B., Graber, H. U., Laurenzi, V. D., Fey, M. F., et al. (2001) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400962 · Cited by 340 · see citing works

MDM2 suppresses p73 function without promoting p73 degradation

Zeng, X., Chen, L., Jost, C. A., Maya, R., Keller, D., Wang, X., Kaelin, W. G., Oren, M., Chen, J., & Lu, H. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3257 · Cited by 334 · see citing works

p63 and p73, the ancestors of p53

Dotsch, V., Bernassola, F., Coutandin, D., Candi, E., & Melino, G. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004887 · Cited by 326 · see citing works

Induction of apoptosis in chronic myelogenous leukemia cells through nuclear entrapment of BCR–ABL tyrosine kinase

Vigneri, P. G., & Wang, J. Y. J. (2001) · Nature Medicine · doi:10.1038/84683 · Cited by 333 · see citing works

A common E2F-1 and p73 pathway mediates cell death induced by TCR activation

Lissy, N. A., Davis, P. K., Irwin, M. S., Kaelin, W. G., & Dowdy, S. F. (2000) · Nature · doi:10.1038/35036608 · Cited by 330 · see citing works

The potential tumor suppressor p73 differentially regulates cellular p53 target genes.

Zhu, J., Jiang, J., Zhou, W., & Chen, X. (1998) · PubMed · Cited by 323 · see citing works

ΔNp73, A Dominant-Negative Inhibitor of Wild-type p53 and TAp73, Is Up-regulated in Human Tumors

Zaika, A., Slade, N., Erster, S. H., Sansome, C., Joseph, T. W., Pearl, M. L., Chalas, E., & Moll, U. M. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020179 · Cited by 316 · see citing works

P53 Is Essential for Developmental Neuron Death as Regulated by the TrkA and p75 Neurotrophin Receptors

Aloyz, R. S., Bamji, S. X., Pozniak, C. D., Toma, J. G., Atwal, J. K., Kaplan, D. R., & Miller, F. D. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.6.1691 · Cited by 302 · see citing works

The Abl family kinases: Mechanisms of regulation and signaling

Pendergast, A. M. (2002) · Advances in cancer research · doi:10.1016/s0065-230x(02)85003-5 · Cited by 296 · see citing works

p63α and ΔNp63α can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes

Dohn, M. R., Zhang, S., & Chen, X. (2001) · Oncogene · doi:10.1038/sj.onc.1204427 · Cited by 294 · see citing works

Progress in understanding the molecular pathogenesis of human lung cancer

Sekido, Y., Fong, K. M., & Minna, J. D. (1998) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(98)00010-9 · Cited by 289 · see citing works

Regulation of cell death by the Abl tyrosine kinase

Wang, J. Y. J. (2000) · Oncogene · doi:10.1038/sj.onc.1203878 · Cited by 278 · see citing works

Motor neuron degeneration in amyotrophic lateral sclerosis mutant superoxide dismutase‐1 transgenic mice: Mechanisms of mitochondriopathy and cell death

Martin, L. J., Liu, Z., Chen, K. Y., Price, A. C., Pan, Y. H., Swaby, J. A., & Golden, W. C. (2006) · The Journal of Comparative Neurology · doi:10.1002/cne.21160 · Cited by 270 · see citing works

Targeting p53 for Novel Anticancer Therapy

Wang, Z., & Sun, Y. (2010) · Translational Oncology · doi:10.1593/tlo.09250 · Cited by 249 · see citing works

Targeting Tumor Suppressor p53 for Cancer Therapy: Strategies, Challenges and Opportunities

Hong, B., van den Heuvel, A. P. J., Prabhu, V. V., Zhang, S., & El‐Deiry, W. S. (2014) · Current Drug Targets · doi:10.2174/1389450114666140106101412 · Cited by 245 · see citing works

Physical and Functional Interaction between p53 Mutants and Different Isoforms of p73

Strano, S., Munarriz, E. R., Rossi, M., Cristofanelli, B., Shaul, Y., Castagnoli, L., Levine, A. J., Sacchi, A., Cesareni, G., Oren, M., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003360200 · Cited by 241 · see citing works

A new human p53 homologue

Trink, B., Okami, K., Wu, L., Sriuranpong, V., Jen, J., & Sidransky, D. (1998) · Nature Medicine · doi:10.1038/nm0798-747 · Cited by 238 · see citing works

Functional association between Wwox tumor suppressor protein and p73, a p53 homolog

Aqeilan, R. I., Pekarsky, Y., Herrero, J. J., Palamarchuk, A., Letofsky, J., Druck, T., Trapasso, F., Han, S., Melino, G., Huebner, K., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400805101 · Cited by 236 · see citing works

TAp73 enhances the pentose phosphate pathway and supports cell proliferation

Du, W., Jiang, P., Mancuso, A., Stonestrom, A. J., Brewer, M. D., Minn, A. J., Mak, T. W., Wu, M., & Yang, X. (2013) · Nature Cell Biology · doi:10.1038/ncb2789 · Cited by 234 · see citing works

ASPP1 and ASPP2: Common Activators of p53 Family Members

Bergamaschi, D., Samuels, Y., Jin, B., Duraisingham, S., Crook, T., & Lü, X. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.3.1341-1350.2004 · Cited by 229 · see citing works

p53 Regulates Cell Cycle and MicroRNAs to Promote Differentiation of Human Embryonic Stem Cells

Jain, A. K., Allton, K. L., Iacovino, M., Mahen, E. M., Milczarek, R. J., Zwaka, T. P., Kyba, M., & Barton, M. C. (2012) · PLoS Biology · doi:10.1371/journal.pbio.1001268 · Cited by 226 · see citing works

Physical Interaction with Human Tumor-derived p53 Mutants Inhibits p63 Activities

Strano, S., Fontemaggi, G., Costanzo, A., Rizzo, M. G., Monti, O., Baccarini, A., Sal, G. D., Levrero, M., Sacchi, A., Oren, M., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201405200 · Cited by 225 · see citing works

Clinical implications of p53 mutations

Wallace-Brodeur, R. R., & Lowe, S. W. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050270 · Cited by 223 · see citing works

p53 family update: p73 and p63 develop their own identities.

Irwin, M. S., & Kaelin, W. G. (2001) · PubMed · Cited by 222 · see citing works

Apoptosis in Myocardial Ischemia‐Reperfusion

Gottlieb, R. A., & Engler, R. L. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09255.x · Cited by 213 · see citing works

Mdm2 binds p73α without targeting degradation

Bálint, E., Bates, S., & Vousden, K. H. (1999) · Oncogene · doi:10.1038/sj.onc.1202781 · Cited by 212 · see citing works

Frequent alteration of p63 expression in human primary bladder carcinomas.

Park, B.-J., Lee, S. J., Kim, J. I., Lee, S., Lee, C. H., Chang, S. G., Park, J. H., & Chi, S. G. (2000) · PubMed · Cited by 209 · see citing works

Expression of p73 and Reelin in the Developing Human Cortex

Meyer, G., Pérez‐García, C. G., Ábrahám, H., & Caput, D. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-12-04973.2002 · Cited by 204 · see citing works

TP53 family members and human cancers

Bénard, J., Douc‐Rasy, S., & Ahomadegbe, J. (2003) · Human Mutation · doi:10.1002/humu.10172 · Cited by 205 · see citing works

A C-Terminal Inhibitory Domain Controls the Activity of p63 by an Intramolecular Mechanism

Serber, Z., Lai, H. C., Yang, A., Ou, H. D., Sigal, M. S., Kelly, A. E., Darimont, B. D., Duijf, P. H. G., van Bokhoven, H., McKeon, F., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.24.8601-8611.2002 · Cited by 203 · see citing works

Neuronal life and death: an essential role for the p53 family

Miller, F. D., Pozniak, C. D., & Walsh, G. S. (2000) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400736 · Cited by 201 · see citing works

Evolutionary conservation and somatic mutation hotspot maps of p53: correlation with p53 protein structural and functional features

Walker, D. R., Bond, J. P., Tarone, R. E., Harris, C. C., Makalowski, W., Boguski, M. S., & Greenblatt, M. S. (1999) · Oncogene · doi:10.1038/sj.onc.1202298 · Cited by 198 · see citing works

Viral Oncoproteins Discriminate between p53 and the p53 Homolog p73

Marín, M. C., Jost, C. A., Irwin, M. S., DeCaprio, J. A., Caput, D., & Kaelin, W. G. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.11.6316 · Cited by 193 · see citing works

Overexpression of the wild type p73 gene in breast cancer tissues and cell lines.

Zaika, A., Kovalev, S. Y., Marchenko, N. D., & Moll, U. M. (1999) · PubMed · Cited by 191 · see citing works

Loss of p73 gene expression in leukemias/lymphomas due to hypermethylation.

Kawano, S., Cw, M., Gombart, A., Bartram, C., Matsuo, Y., Asou, H., Sakashita, A., Said, J. W., Tatsumi, E., & Koeffler, H. P. (1999) · PubMed · doi:10.1182/blood.v94.3.1113.415k33_1113_1120 · Cited by 189 · see citing works

Apoptosis of leukemic cells accompanies reduction in intracellular pH after targeted inhibition of the Na+/H+exchanger

Rich, I. N., Worthington‐White, D. A., Garden, O. A., & Musk, P. (2000) · Blood · doi:10.1182/blood.v95.4.1427.004k48_1427_1434 · Cited by 188 · see citing works

Role of p53 family members in apoptosis

Sheikh, M. S., & Fornace, A. J. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200002)182:2 · Cited by 182 · see citing works

(−)-Gossypol acts directly on the mitochondria to overcome Bcl-2- and Bcl-XL-mediated apoptosis resistance

Oliver, C. L., Miranda, M. B., Shangary, S. K., Land, S. R., Wang, S., & Johnson, D. E. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.23.4.1 · Cited by 182 · see citing works

The p53 tumour suppressor gene

Steele, R. J., Thompson, A. M., Hall, P. A., & Lane, D. P. (1998) · British journal of surgery · doi:10.1046/j.1365-2168.1998.00910.x · Cited by 184 · see citing works

Induction of Neuronal Differentiation by p73 in a Neuroblastoma Cell Line

Laurenzi, V. D., Raschellà, G., Barcaroli, D., Annicchiarico‐Petruzzelli, M., Ranalli, M., Catani, M. V., Tanno, B., Costanzo, A., Levrero, M., & Melino, G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.20.15226 · Cited by 183 · see citing works

Pin1 Links the Activities of c-Abl and p300 in Regulating p73 Function

Mantovani, F., Piazza, S., Gostissa, M., Strano, S., Zacchi, P., Mantovani, R., Blandino, G., & Sal, G. D. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.05.007 · Cited by 181 · see citing works

Regulating the p53 system through ubiquitination

Yang, Y., Li, C.-C. H., & Weissman, A. M. (2004) · Oncogene · doi:10.1038/sj.onc.1207411 · Cited by 179 · see citing works

Possible oncogenic potential of DeltaNp73: a newly identified isoform of human p73.

Ishimoto, O., Kawahara, C., Enjo, K., Obinata, M., Nukiwa, T., & Ikawa, S. (2002) · PubMed · Cited by 177 · see citing works

Autoinhibitory Regulation of p73 by ΔNp73 To Modulate Cell Survival and Death through a p73-Specific Target Element within the ΔNp73 Promoter

Nakagawa, T., Takahashi, M., Ozaki, T., Watanabe, K., Todo, S., Mizuguchi, H., Hayakawa, T., & Nakagawara, A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.8.2575-2585.2002 · Cited by 176 · see citing works

The p53 gene family

Kaelin, W. G. (1999) · Oncogene · doi:10.1038/sj.onc.1202955 · Cited by 172 · see citing works

Transactivation-deficient ΔTA-p73 Inhibits p53 by Direct Competition for DNA Binding

Stiewe, T., Theseling, C. C., & Pützer, B. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200480200 · Cited by 173 · see citing works

The p53 Family Member Genes Are Involved in the Notch Signal Pathway

Sasaki, Y., Ishida, S., Morimoto, I., Yamashita, T., Kojima, T., Kihara, C., Tanaka, T., Imai, K., Nakamura, Y., & Tokino, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108080200 · Cited by 172 · see citing works

Senescence Regulation by the p53 Protein Family

Qian, Y., & Chen, X. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-239-1_3 · Cited by 170 · see citing works

Solution structure of a conserved C‐terminal domain of p73 with structural homology to the SAM domain

Chi, S.-W., Ayed, A., & Arrowsmith, C. H. (1999) · The EMBO Journal · doi:10.1093/emboj/18.16.4438 · Cited by 169 · see citing works

Interaction of mismatch repair protein PMS2 and the p53-related transcription factor p73 in apoptosis response to cisplatin

Shimodaira, H., Yoshioka-Yamashita, A., Kolodner, R. D., & Wang, J. Y. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0438031100 · Cited by 165 · see citing works

The nuclear function of p53 is required for PUMA-mediated apoptosis induced by DNA damage

Wang, P., Yu, J., & Zhang, L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700020104 · Cited by 164 · see citing works

Inactivation of the p53-homologue p73 by the mdm2-oncoprotein

Dobbelstein, M., Wienzek, S., König, C., & Roth, J. (1999) · Oncogene · doi:10.1038/sj.onc.1202512 · Cited by 161 · see citing works

Expression of p73 and Its Relation to Histopathology and Prognosis in Hepatocellular Carcinoma

Tannapfel, A., Wasner, M., Krause, K., Geißler, F., Katalinic, A., Hauss, J., Mössner, J., Engeland, K., & Wittekind, C. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.13.1154 · Cited by 162 · see citing works

p73 and p63 Are Homotetramers Capable of Weak Heterotypic Interactions with Each Other but Not with p53

Davison, T. S., Vagner, C., Kaghad, M., Ayed, A., Caput, D., & Arrowsmith, C. H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.26.18709 · Cited by 160 · see citing works

Role of p73 in malignancy: tumor suppressor or oncogene?

Stiewe, T., & Pützer, B. M. (2002) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400995 · Cited by 156 · see citing works

Promoter specificity and stability control of the p53-related protein p73

Lee, C., & Thangue, N. B. L. (1999) · Oncogene · doi:10.1038/sj.onc.1202793 · Cited by 153 · see citing works

Tumor suppressor p53: regulation and function

Somasundaram, K. (2000) · Frontiers in bioscience · doi:10.2741/somasund · Cited by 152 · see citing works

A DNA damage and stress inducible G protein-coupled receptor blocks cells in G 2 /M

Weng, Z., Fluckiger, A.-C., Nisitani, S., Wahl, M. I., Le, L. Q., Hunter, C. A., Fernal, A. A., Beau, M. M. L., & Witte, O. N. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12334 · Cited by 151 · see citing works

Biochemical and Genetic Control of Apoptosis: Relevance to Normal Hematopoiesis and Hematological Malignancies

Wickremasinghe, R. G., & Hoffbrand, A. V. (1999) · Blood · doi:10.1182/blood.v93.11.3587 · Cited by 151 · see citing works

Genomic Imprinting and Cancer

Jirtle, R. L. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4453 · Cited by 149 · see citing works

Splitting p63

van Bokhoven, H., & Brunner, H. G. (2002) · The American Journal of Human Genetics · doi:10.1086/341450 · Cited by 149 · see citing works

New p73 variants with altered C-terminal structures have varied transcriptional activities

Ueda, Y., Hijikata, M., Takagi, S., Chiba, T., & Shimotohno, K. (1999) · Oncogene · doi:10.1038/sj.onc.1202817 · Cited by 149 · see citing works

p53 Family members p63 and p73 are SAM domain‐containing proteins

Thanos, C. D., & Bowie, J. U. (1999) · Protein Science · doi:10.1110/ps.8.8.1708 · Cited by 148 · see citing works

SIRT1 interacts with p73 and suppresses p73‐dependent transcriptional activity

Dai, J. M., Wang, Z. Y., Sun, D. C., Lin, R. X., & Wang, S. Q. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20831 · Cited by 147 · see citing works

Receptor tyrosine kinase EphA2 is regulated by p53-family proteins and induces apoptosis

Dohn, M. R., Jiang, J., & Chen, X. (2001) · Oncogene · doi:10.1038/sj.onc.1204816 · Cited by 146 · see citing works

Differential regulation of transcription and induction of programmed cell death by human p53‐family members p63 and p73

Dietz, S., Rother, K., Bamberger, C., Schmale, H., Mössner, J., & Engeland, K. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03093-4 · Cited by 59 · see citing works

New Monoclonal Antibodies Recognizing the p53 Tumour Suppressor Protein Homologue p73

Češková, P., Nenutil, R., Bray, S. E., Svitáková, M., Babcanová, S., Uldrijan, S., & Vojtěšek, B. (2001) · Folia Biologica · doi:10.14712/fb2001047060211

p73, a sophisticated p53 family member in the cancer world

Ozaki, T., & Nakagawara, A. (2005) · Cancer Science · doi:10.1111/j.1349-7006.2005.00116.x · Cited by 137 · see citing works

p73 can suppress the proliferation of cells that express mutant p53

Willis, A. C., Pipes, T., Zhu, J., & Chen, X. (2003) · Oncogene · doi:10.1038/sj.onc.1206505 · Cited by 25 · see citing works

The Emerging p53 Gene Family

Kaelin, W. G. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.7.594 · Cited by 142 · see citing works